ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory

Stock Information for ClearPoint Neuro, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ClearPoint Neuro, Inc.

ClearPoint Neuro Reports First Quarter 2024 Results
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT)
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR(TM) Stereotactic System
ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT)
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza(TM) as a Treatment for AADC Deficiency

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.